Tag: Testimonial

Impact Journals provides superior publishing services to all of our authors—including world-renowned scientists and researchers from leading-edge universities and institutions.

Hear what the authors have to say about their experience publishing research papers with Oncotarget in the testimonials below.

Oncotarget News

Dr. Mark Woodford
Oncotarget

Testimonial: Dr. Mark Woodford

May 3, 2022
Dr. Mark Woodford, Assistant Professor at the Department of Urology, SUNY Upstate Medical University, Syracuse, NY, describes his experience publishing the meeting report, “Seventh BHD international symposium: recent scientific and... read more
Dr. Dean Felsher
Oncotarget

Testimonial: Dr. Dean Felsher

January 20, 2022
Below is a transcript of the testimonial from Dr. Dean Felsher from Stanford University School of Medicine, Departments of Medicine and Pathology and member of Oncotarget’s Founding Editorial Board,... read more
Dr. Jennifer Sheng
Oncotarget

Testimonial: Dr. Jennifer Sheng

December 10, 2021
Dr. Jennifer Sheng from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center shares her experience publishing "Innovating and expanding weight loss strategies for breast cancer survivors" with Oncotarget.Dr. Jennifer... read more
Dr. Gina Abdelaal
Oncotarget

Testimonial: Dr. Gina Abdelaal

December 3, 2021
Dr. Gina Abdelaal from Northumbria University discusses her experience publishing “Reversing oncogenic transformation with iron chelation,” with Oncotarget.Dr. Gina AbdelaalI selected Oncotarget because I remember... read more
Dr. Monica Varun Tyagi
Oncotarget

Testimonial: Dr. Monica Varun Tyagi

November 25, 2021
Dr. Monica Varun Tyagi discusses her experience publishing “GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3,” with Oncotarget.Dr. Monica... read more
Dr. Michael Roehrl
Oncotarget

Testimonial: Dr. Michael Roehrl

November 19, 2021
Dr. Michael Roehrl from the Department of Pathology, Memorial Sloan Kettering Cancer Center discusses his experience while publishing the paper, “Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal... read more